Tick-borne diseases (TBD) in dogs have gained in significance in German and Austrian veterinary practices. The widespread European tick species Ixodes ricinus represents an important vector for spirochaetes of the Borrelia burgdorferi sensu lato group and Rickettsiales such as Anaplasma phagocytophilum. The meadow or ornate dog tick (Dermacentor reticulatus) is an important vector for Babesia canis, as is the brown dog tick (Rhipicephalus sanguineus) for Babesia vogeli in the Mediterranean region. The present work covers pathogen transmission by tick vectors, including the mechanisms and the minimum intervals required, in conjunction with possible non-vector-borne transmission routes. It also addresses the incubation periods, pathogenicity and clinical findings associated with each pathogen and genospecies and presents case examples. Current data on prevalence, annual fluctuations and distribution in various pre-selected dog populations (symptomatic versus asymptomatic) in both countries are depicted in maps. Reasons for changes in prevalence (especially of Borrelia) are discussed. Criteria and algorithms for clinical diagnosis and monitoring in dogs, including case history, direct detection (blood smears, molecular detection by species-specific PCR and sequencing) and indirect methods (whole-cell and peptide-based antibody tests), are presented, together with laboratory abnormalities (haematology, clinical chemistry, urine). The role
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Introduction
Tick-borne diseases (TBD) in dogs have gained in significance in German and Austrian veterinary practices. The widespread European tick species Ixodes ricinus is a major vector of spirochaetes from the Borrelia burgdorferi sensu lato complex (Bbsl) and Rickettsiales such as Anaplasma phagocytophilum. The meadow or ornate dog tick (Dermacentor reticulatus) is an important vector for Babesia canis, as is the brown dog tick (Rhipicephalus sanguineus) for Babesia vogeli in the Mediterranean region (Table 1) . B. burgdorferi, the pathogen responsible for Lyme borreliosis (LB), was named after Dr. Willy Burgdorfer, who first discovered the bacterium in ticks in 1981 (reviewed by Horst 2003; Skotarczak 2014) . They represent relatively large, helical-shaped (spiral) bacteria belonging to the spirochaetes (order Spirochaetales). The Bbsl complex currently comprises 19 species, including at least five genospecies pathogenic to humans (Borrelia burgdorferi sensu stricto / Bbss, Borrelia afzelii, Borrelia bavariensis, Borrelia garinii and Borrelia spielmanii; Herzberger et al. 2007; Krupka and Straubinger 2010; Margos et al. 2013; Tijsse-Klasen et al. 2013b ).
Based on current information, pathogenicity (in the course of experimental and natural infections) in the dog has been demonstrated conclusively only for Bbss, especially in the light of Koch's postulates complying after experimental infections (Hovius et al. 2000; Straubinger 2000; Straubinger et al. 2000; Liebisch and Liebisch 2003a; Littman et al. 2006; Wagner et al. 2012; Skotarczak 2014) . A. phagocytophilum is an obligate intracellular gram-negative bacterium, belonging to the order of Rickettsiales. This bacterium replicates mainly in neutrophils and can cause disease in humans, horses, dogs, cats and ruminants (Huhn et al. 2014) . Since 2001, the former species Ehrlichia equi and Ehrlichia phagocytophila, and the agent responsible for human granulocytic ehrlichiosis ("HGE agent"), have been reclassified as a new species A. phagocytophilum on the basis of molecular data (16S rRNA gene; Dumler et al. 2001) . These bacteria bind to glycoproteins on the surface of neutrophils and are incorporated into the cells through caveolae-mediated endocytosis. Thereafter, they prevent endosome-lysosome fusion and reproduce in membrane-bound vesicles, forming microcolonies called morulae (Carrade et al. 2009 ). A recent study showed furthermore that A. phagocytophilum was able to invade endothelial cells in vitro and that transmission of bacteria from microvascular endothelial cells to granulocytes occurred under flow conditions (Wang et al. 2015) . Babesia are protozoan agents belonging to the piroplasms (family Babesiidae, order Piroplasmida), and are the most important blood parasites found in domestic mammals. Canine babesiosis occurs worldwide. Intraerythrocytic parasites in dogs with symptoms comparable with babesiosis (fever, anaemia, splenomegaly) were first described in South Africa in 1893; in Europe, they were first described in Italy in 1895, some years after bovine babesiosis was first described by the Romanian Victor Babes in 1888 (Babes 1888; Piana and GalliValerio 1895; Baneth 2013) . Until a few years ago, canine babesiosis was induced by three species of a large Babesia (merozoite size 3 -5 μm), Babesia canis, Babesia vogeli and Babesia rossi (formerly Babesia canis subsp. canis, B. canis subsp. vogeli and B. canis subsp. rossi), and one small Babesia (1 -3 μm), B. gibsoni (Uilenberg et al. 1989; Zahler et al. 1998; Carret et al. 1999; Irwin 2009; Ogo et al. 2011) . Recently, however, molecular studies resulted in the addition of further species. There are now at least nine genetically different species recognized (Tables 2 -3 ). The recent findings of Babesia annae in foxes in Germany, Austria and Hungary (see Table 3 ) are intriguing, as no concurrent infections in dogs were reported from the corresponding areas. The provisional assignment of this agent as "Theileria annae" is controversial, because the organism is phylogenetically closer to Babesia microti. Typical features of the genus Theileria, such as pre-erythrocytic stages or paucity of transovarial transmission in the tick vector, have not been proven for B. annae (Dixit et al. 2010; Simões et al. 2011) . One current study assign this organism as Babesia vulpes sp. nov., after its natural host Vulpes vulpes . laboratories where they were investigated using a serological rapid test (SNAP ® 4Dx ® ) for the presence of specific antibodies to Borrelia C6 antigen (not induced by vaccination, see below). In group A, 7.7 % of the dogs (232 / 3,005; 95 % confidence interval (CI): 6.8 -8.7) and 11.8 % of the dogs in group B (340 / 2,876; 95 % CI: 10.7 -13.1) tested positive (statistically significant difference of p < 0.001; chi-square (CS) test). Overall, regional seroprevalences of 1.9 % to 10.3 % were found for B. burgdorferi (group A). Similar seroprevalence was observed for humans in a recent study from Germany (9.4 %; 741 / 6,945), with significant correlation for seropositivity in southern Germany, male sex and residence in rural areas. Interestingly, having a dog / cat in the house was not associated with a higher risk for seropositivity (Wilking et al. 2015) . Within the above mentioned canine group A 3 % of the dogs (91 / 3,005; 95 % CI: 2.4 -3.7) also showed antibodies to A. phagocytophilum (Fig. 1) .
The seroprevalence for A. phagocytophilum (total samples tested 5,683; antibodies to MSP2 (P44) antigen) was 21.5 % (95 % CI: 20.5 -22.6). It can therefore be assumed that at least one fifth of dogs in Germany had contact with this agent. Overall, regional seroprevalences of 17.6 % to 31.1 % were found for Anaplasma spp. (Krupka et al. 2007 ). In comparison, the seroprevalence with the same test (SNAP ® 4Dx ® ) for Borrelia and Anaplasma in Poland (3,094 canine samples) was 3.75 % and 12.31 %, respectively (Krämer et al. 2014 ). Even lower rates (1.09 % for Borrelia and 2.72 % for Anaplasma) were found in in France (the same test; 919 dogs; Pantchev et al. 2009 ). To document the presence of A. phagocytophilum and Bbsl in dogs in Austria, routine diagnostic data from the authors' laboratory were evaluated retrospectively (previously unpublished data; methods according to Dyachenko et al. 2012) . In April/May 2011, Anaplasma spp. real-time PCR was used to Croatia molecular detection only *shows weak virulence for adult dogs but can also take a severe course in the presence of predisposing factors (young dogs, immunosuppression (Cushing's disease, corticosteroid administration or co-infections)); **apparently the Babesia species from NC ("Babesia sp. coco") affect mainly immunosuppressed dogs; in vitro, it shows few ultrastructural differences compared to other Babesia spp.; according to the phylogenetic results (18S rRNA) of a current study, this large piroplasm from NC could be related to the genus Rangelia (Eiras et al. 2014) positive test a total of 50 EDTA blood samples submitted by veterinarians in Austria (this test had been specifically requested, so the dogs were presumably showing clinical signs of infection). Eight out of 50 samples (16 %; 95 % CI: 7.1 -29.1) tested positive. In comparison, a total of 30 samples were tested in the same period in 2010; five of these tested positive (16.7 %; 95 % CI: 5.5 -34.7). One hundred and sixty-four dogs were tested serologically for antibodies to Borrelia spp. C6 antigen in April/ May 2011 (serum samples; again submitted by Austrian veterinary surgeons specifically requesting this test), and seven were positive (4.3 %; 95 % CI: 1.7 -8.6). In comparison, a total of 90 samples were tested in the same period in 2010; five of these tested positive (5.6 %; 95 % CI: 1.8 -12.5). Strikingly, much larger numbers of samples were submitted for both tests in 2011 (increases of approx. 67 % and 83 % respectively compared with 2010). However, the differences in positive percentages for the two years were not statistically significant (p = 0.644 for Borrelia and p = 0.938 for Anaplasma spp.; CS test). Regarding the distribution of positive samples, some federal states showed an overlapping incidence of both organisms (Vienna, Lower/Upper Austria and Carinthia). In other regions, only Anaplasma (Vorarlberg, Styria and Burgenland) or only Borrelia (Tirol) was detected. Salzburg was the only state with no positive cases (Fig. 2) . Previously, canine babesiosis was typically associated with travel to Mediterranean countries. In a study conducted in 2005 and 2006, blood samples from 5,483 dogs living in Germany with a history of travel were tested for relevant pathogens. Babesia species (DNA detection by means of conventional PCR technique) were detected in 2.4 % of these samples (Hirsch and Pantchev 2008) . However, canine babesiosis is increasingly endemic in both Germany (Barutzki et al. 2007 ) and Switzerland Table 3 Current Babesia / Theileria species in the dog (small forms): at least five genetically different species (according to Zahler et al. 2000a,b; Beck et al. 2009; Irwin 2009; Birkenheuer 2012; Falkenö et al. 2013; Najm et al. 2014; Duscher et al. 2014; Gallusova et al. 2014; Rosa et al. 2014; Baneth et al. 2015; Farkas et al. 2015) . Schaarschmidt et al. 2013) . This is believed to be the result of dogs introducing infected ticks, which have subsequently found suitable biotopes (for example, due to re-naturalization of agricultural areas) and climatic conditions (Heile et al. 2006) . In a recent study, a new B. canis ELISA was used to test 4,579 canine samples from Germany for B. canis antibodies as part of travel disease profiles (no immediate suspicion of babesiosis) and 937 samples from dogs with suspected babesiosis (Pantchev 2012a) . Because a travel disease profile had been ordered, the dogs in the first group were assumed to have travelled outside Germany; in the second group, a history of travel could not be entirely ruled out. According to the test manufacturer, the sensitivity and the specificity of the B. canis ELISA compared with the indirect immunofluorescence assay (IFA) (671 sera tested using four different IFAs) are 91.6 % and 95.4 %, respectively. In relation to a "gold standard" IFA validated at a university institute according to strict scientific criteria (287 sera), sensitivity and specificity are as high as 96. . This whole-cell based assay can therefore be regarded as more piroplasma-specific. Three hundred and nineteen dogs (travel disease profile) within the above-mentioned study tested positive for antibodies (7 %; 95 % CI: 6.2 -7.7) and a further 112 samples were borderline (2.4 %). In dogs with suspected babesiosis, higher proportions of samples were seropositive (12.7 %; 95 % CI: 10.6 -15; significant difference of p < 0.001, CS test) and 3.5 % of samples were borderline. Regarding the distribution of positive samples in both groups within the German federal states, it can be observed, that only dogs with a history of travel tested positive in four federal states, and one state had no cases at all (Fig. 3) . Whether this result is due to the absence of endemic canine babesiosis in these states, or to the simple fact that insufficient samples were submitted, should be a subject for further studies.
Species
The occurrence and distribution of B. canis infection in dogs in Austria was established using the same Babesia ELISA (see above; previously unpublished data). The serum samples were submitted to the authors' laboratory by veterinarians in Austria from 2012 to 2013. Two hundred and fifty-nine samples in group 1 were tested either in response to a direct request for a Babesia spp. antibody test (n = 70; 27 %) or as a part of a serological tick profile (n = 189; 73 %). As a comparison, a second group was assessed over the same time period (group 2; n = 172). Animals in group 2 were assumed to have a travel history, because the serum samples were submitted by the veterinarian as part of a travel disease profile. In group 1 (mostly comprising "tick profiles") 28 samples tested positive (10.8 %; 95 % CI: 7.3 -15.2; red in Fig. 4 ) and 6 samples were borderline (2.3 %). As part of the travel disease profile, however, only 8 dogs tested positive (4.7 %; 95 % CI: 2 -9; blue in Fig. 4 ), which is significantly fewer than in group 1 (p = 0.024; CS test). Additionally, six samples in group 2 tested borderline (3.5 %). As can be deduced from Figure 4 , there appears to be a cluster of seropositive dogs in the eastern part of Austria.
Pathogen transmission and incubation period
Various mechanisms are required to activate the relevant pathogen in the tick. In general, transmission of bacteria and parasites does not occur immediately. The shortest transmission intervals reported are 16 to 65 hours for Borrelia and 24 hours for Anaplasma (Crippa et al. 2002; Kahl et al. 1998; Diniz and Breitschwerdt 2012) . Borrelia spp. produce various outer surface proteins ("Osp"), which enable the spirochaetes to adapt to a wide range of environmental conditions (Kenedy et al., 2012) . Borrelia organisms in the tick's gut express mainly OspA, which allows the bacteria to adhere to the tick receptor for OspA ("TROSPA"; Tsao 2009). Contact with the host's skin causes a temperature rise in the tick, which triggers an activity signal in Borrelia organisms, enabling them to migrate from the tick's gut to its salivary glands. Following contact with blood, OspA (and OspB) are replaced within 36 to 48 hours by newly produced OspC, which binds to the tick salivary protein Salp15 (Kenedy et al. 2012) . After 24 to 48 hours, Borrelia organisms are transmitted to the dog (Radolf and Caimano 2008; Straubinger and Pantchev 2010) . In the mammalian host, origin of seropositive dogs in group 1 (predominantly tested as part of a tick profile; red, n = 28) and group 2 ("travel disease profile"; blue, n = 8; map produced using RegioGraph, positions correspond to submitters' postcodes).
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spirochaetes express the protein VlsE (variable major protein-like sequence, expressed) on their surface. The variability of this protein allows Borrelia to evade the host's immune defences (Kenedy et al. 2012) . A shift in the outer surface proteins seems to be crucial for infection (Appel et al. 1993; Radolf and Caimano 2008) . In experimental studies it was shown that the incubation period in the dog is between two and five months (Appel et al. 1993; Straubinger 2000; Straubinger et al. 2000; Wagner et al. 2012) . Therefore, no clinical signs were observed in dogs that had not previously seroconverted (Appel et al. 1993) . In contrast, the incubation period for anaplasmosis following a tick bite or experimental (i.v.) infection is reported to be 1 to 2 weeks (Scorpio et al. 2011; Diniz and Breitschwerdt 2012) , which can precede seroconversion (see below). Shorter transmission intervals may exceptionally occur. For example, occasional cases of systemic infection with Borrelia spp. in the tick were described, with Borrelia present in the salivary glands before tick attachement (also described for A. phagocytophilum; Crippa et al. 2002; Diniz and Breitschwerdt 2012) . Earlier transmission is also possible, if previously attached (and thus "activated") ticks infest a new host. Moreover, I. ricinus appears to transmit B. afzelii more rapidly than Bbss (Crippa et al. 2002; Moehrle and Rassner 2002) . It is generally assumed that transmission of Bbsl takes place via nymphs and adult ticks, and specifically that larvae become infected by feeding on infected reservoir hosts (e.g. rodents), followed by transstadial transmission of Borrelia (illustrated in Fig. 5 ; applies similarly to A. phagocytophilum). Whether a transovarial transmission of Bbsl can take place in the tick, as proposed following increased molecular detection in larvae in a recent study (Tappe et al. 2014) , or the transovarially transmitted agent is actually Borrelia miyamotoi (Rollend et al. 2013 ), has to be evaluated in further studies. Even if larvae did contain Bbsl in sufficient amounts for transmission, the risk to dogs is put into perspective by the fact that these larvae live primarily at ground level, and their preferred hosts are small mammals and birds (Liebisch and Liebisch 2003b; Greene et al. 2012; Deplazes et al. 2013 ). This is supported by a recent study from Switzerland, in which only 0.5 % of collected ticks from dogs we identified as being larvae (Eichenberger et al. 2015) . Non-vector-borne transmission of A. phagocytophilum in humans through blood transfusions (Annen et al. 2012) or perinatal infection (Horowitz et al. 1998; Dhand et al. 2007 ) has been described. Moreover, transplacental transmission as a result of experimental infection is possible in ruminants (Diniz and Breitschwerdt 2012) and was also confirmed after natural congenital infection in a calf in northern Germany (Henniger et al. 2013) . Vertical transmission of Bbss did not occur under experimental conditions in dogs (maternal antibodies declined to negative 4 weeks postpartum; Appel et al. 1993) . Vertical transmission of Borrelia spp. and other non-vectorborne modes of transmission (via semen, urine, or blood) are unlikely in the dog under natural conditions (Appel et al. 1993; Greene et al. 2012 A striking feature of Babesia species is not only the transstadial but also the efficient transovarial transmission in the tick. By means of vertical transmission to the next 3 to 4 generations, tick populations in an endemic region can remain infected for several years, despite having no opportunity for reinfection (Deplazes et al. 2013 ). This ensures long-term survival in the tick population (distribution strategy; Chauvin et al. 2009 ). This process is limited to some extent because only 10 to 20 % of the tick eggs are infected, and infected females produce fewer eggs (Deplazes et al. 2013) . The development of Babesia in the tick, specifically the infestation of the salivary glands accompanied by the production of sporozoites, does not happen immediately, but is triggered by nervous stimulation of various organs. When ticks attach to the host, developmental stages of Babesia known as kinetes are released. These enter the tick's salivary glands via the haemolymph. Dogs exposed experimentally to D. reticulatus containing B. canis tested positive for Babesia (PCR, blood smears) after a 72-hour infestation; males which had already had a blood meal were an exception in terms of immediate transmission (Heile and Schein 2007) . The same study showed that nymphs already have the ability to transmit B. canis. However, because nymphs rarely infest dogs, this mode of transmission plays only a minor role from an epidemiological perspective. The incubation period of Babesia in the dog is reported to be 7 to 21 days p.i. ( 
Diagnostics Lyme borreliosis (LB)
The presumptive diagnosis of LB in dogs implies several criteria (according to Littman et al. 2006; Krupka and Straubinger 2010) . These include a history with regard to tick exposure and living in endemic regions, diagnostic evidence of infection with the pathogen, exclusion of differential diagnoses, compatible clinical symptoms, and response to specific treatment including monitoring of treatment success. Detection by direct methods (PCR and/or culture) ante mortem is difficult and of little practical relevance. Borrelia organisms are rarely detected in body fluids such as blood ( Fig. 6 ), urine (bladder involvement is also rare), synovial fluid or cerebrospinal fluid (Leschnik et al. 2010; Krimer et al. 2011; Susta et al. 2012) . They are more commonly found in connective tissue, fascias, joint capsule (most promising in the affected joint), skin (near the tick bite), lymph nodes, muscle (including the heart), etc. (frequently in low numbers at the time of detection; Appel et al. 1993; Chang et al. 1996; Straubinger 2000; Chou et al. 2006) . The majority of dogs first develop lameness in the joint closest to the site of tick attachment, which further supports the fact that B. burgdoferi does not disseminate throughout the body via the blood stream (Straubinger et al. 1998) . Direct methods in many cases produce false-negative results, because tissue samples commonly contain few or no bacteria at the time of collection, so serology is widely used. However, the only reliable way to differentiate the genospecies is direct detection followed by molecular characterization (as is frequently performed in tick studies; Skotarczak 2014), because the relevant antigens display serological cross-reactivity (Hovius et al. 2000) . As a result, it is not currently possible to use different serological tests (enzyme immunoassays or immunoblots) based on individual genospecies or their antigens to perform reliable serological differentiation (Kurzova et al. 2014) . Four aspects should be considered when interpreting positive serological results. Serological tests detect circulating antibodies to an infectious agent, which may indicate active infection with that agent, previous infection or exposure, vaccination, or cross-reactivity with another (generally closely related) organism. These points should be considered, when evaluating serological tests for Borrelia spp.-specific antibodies. In human and veterinary medicine, antibody detection using specific peptides such as C6 is becoming increasingly popular (e.g. Liang et al. 1999a; Embers et al. 2007; Krupka and Straubinger 2010; Wagner et al. 2012 ), as they show advantages over other methods, taking into account the four points mentioned above. The C6 peptide is part of VlsE, a 35-kDa surface lipoprotein of Borrelia burgdorferi (Kenedy et al. 2012 Liang et al. 1999b; Embers et al. 2007 ; Fig. 7 ). In addition, C6 is conserved among different Borrelia species (Liang et al. 2000a ). The VlsE gene locus is located on a plasmid (lp28 -1; Brisson et al. 2012; Embers et al. 2012 ), its expression is suppressed in the tick (Bykowski et al. 2006; Tilly et al. 2013) and drastically upregulated in the host. Moreover, recombination takes place only in the host, not in the tick or in in vitro cultures (Lin et al. 2009 ). Antibodies to Borrelia C6 antigen are not induced by vaccination in the dog (O'Connor et al. 2004; Goldstein et al. 2007) , possibly due to lost of VlsE expression after repeated serial passage of cultured spirochaetes (Liang et al. 1999a,b; O'Connor et al. 2004; Lin et al. 2009 ). According to current scientific knowledge, VlsE is also one of the most important virulence factors of Lyme borreliae, preventing their elimination by the immune system and triggering a persistent infection in the host. This is made possible by constant alternation in the six variable regions (Lin et al. 2009; Brisson et al. 2012; Kenedy et al. 2012 ). Straubinger et al. 2002; Töpfer 2005) . Anti-C6 antibodies also represent an early marker of infection from 21 to 35 days p.i. (Wagner et al. 2012) and persist for at least 12 months in untreated dogs (Levy et al. 2008) . After treatment, anti-C6 antibody concentrations (ACAC) may drop within 3 to 6 months (a decrease of more than 58.3 % was seen after 6 months in animals with an initial concentration over 29 U/ml; Levy et al. 2008) , whereas the values in whole-cell-based tests and OspFbased tests do not fall to the same extent (Straubinger 2000; Straubinger et al. 2000; Littman 2013; Fig. 8) . Additionally, Goldstein et al. (2007) showed a 93 % correlation between a commercially available C6 test and an immunoblot test with regard to the diagnosis of natural infection in the dog. Thus the last two criteria (antibody persistence and decrease in concentration after treatment) also emphasize that C6 can be viewed as a marker of active infection and can be used to monitor treatment success. This has also been shown in experimental infection in monkeys (Embers et al. 2012) . 
S31
For correct diagnosis it is also important to rule out potential differential diagnoses, bearing in mind the travel history of the dog and potential infections from abroad such as Leishmania infantum or Ehrlichia canis. Useful tests in this regard are listed by Littman et al. (2006) , Greene et al. (2012) and Pantchev (2012b) . They include the following examinations: routine laboratory tests (haematology, clinical chemistry, urine analysis), tests for other infectious agents (serology, PCR and antigen detection if necessary) and immune-mediated diseases (rheumatoid factor, antinuclear antibodies or Coombs test), x-rays of one or more limbs, joint tap for cytology and culture (up to 76,000 cells/ microlitre (normal <3000), up to 97% of cells neutrophils (Straubinger et al. 1998) , increased protein concentration and turbidity are compatible with Lyme arthritis), tumour detection (thoracic x-ray, abdominal ultrasound, fine needle aspiration of lymph nodes and bone marrow cytology). The procedure for a Borrelia-positive dog is shown in Fig. 9 . Additionally, Susta et al. (2012) found an inflamed or borderline synovial aspirate (100-cell differential count; inflamed if > 20 % neutrophils, borderline at 8 -19 % and non-inflamed when < 8 % neutrophils) in 47 % (8 / 17) of experimentally infected dogs. Moreover, post-mortem histopathological scoring of the synovial membrane (elbows and stifles), using a proposed grading scheme, was a reliable method for discriminating infected and non-infected animals (88.2 % sensitivity and 100 % specificity). As Fig. 9 shows, it is important to test Borreliapositive dogs for proteinuria. An association is assumed between Borrelia infection and renal disease, termed "Lyme-associated protein-losing nephropathy" (PLN) or "Lyme nephritis" (LN). In single studies, breeds commonly affected included labrador retriever, golden retriever and sheltie. In one study, 17 out of 20 Bernese mountain dogs were seropositive (IgG-IFA), but, because the immunohistochemical studies were negative, a familial nephropathy was assumed (Minkus et al. 1994) . Dogs with suspected LN were younger (53 % < 5 years with an average of 5.6 years) than dogs with similar diseases of different genesis (7.1 years for glomerulonephritis and 7.8 years for amyloidosis). There was no gender predisposition, and the animals were usually presented in summer and autumn with acute or chronic kidney disease accompanied by anorexia, vomitus, thromboembolism, hypertension, oedema, oliguria or pigmenturia (Dambach et al. 1997; Littman et al. 2006; Chou et al. 2006; Goldstein et al. 2013; Littman 2013) . Clinical signs associated with the central nervous system (CNS) can also occur in association with nephropathy, for example as a consequence of vasculitis, hypertension, thromboembolism and uraemic encephalopathy. Laboratory abnormalities include non-regenerative anaemia, thrombocytopenia, hypoalbuminaemia, azotaemia, hyperphosphataemia and proteinuria, with a urine specific gravity below 1.022. In contrast to leptospirosis, LN is not the consequence of direct renal invasion of spirochaetes, but it is regarded as an immune-mediated disease. It is described as an infection-related sterile immune-complex glomerulonephritis with deposition of Borrelia-specific antigen-antibody complexes. This renal form is frequently IHCpositive for antigen but PCR-negative for DNA, with a p.i. disease incidence of 1.85 % (Dambach et al. 1997; Chou et al. 2006; Hovius 2013; Littman 2013) . In regard to histopathology, LN is presented as an immune-mediated membranoproliferative glomerulonephritis ("MPGN"), combined with lympho-plasmocytic interstitial infiltrates and tubulonephrosis. In one study, 27 out of 32 dogs (84 %) with glomerulonephritis diagnosed by histology showed positive IHC staining of renal tissues (rabbit-derived polyclonal antiserum directed against a whole-cell preparation of B. burgdorferi strain B31 was used; Chou et al. 2006) . Currently, it is not well understood whether LN is underrecognized, whether mild or early forms exist, and whether it responds to early intervention. According to Littman (2013) Goldstein et al. 2013) LN, although some attempts to fill this gap were made in the past. Despite monthly tick prophylaxis, a study group of dogs showed 18.7 % seropositivity using a C6-antibody-based test (SNAP ® 3Dx ® ), but no correlation with microalbuminuria (present in 6.1 %; E.R.D. HealthScreen Urine Test) was found (Goldstein et al. 2007 ). This group consisted of young, clinically normal labradors and golden retrievers (median age 1.5 years; n = 268), in a Lyme-endemic region in the USA. However, this study only compared qualitative C6 seropositivity with microalbuminuria, and then only in young dogs. In experimentally infected dogs, Susta et al. (2012) found an urine protein: creatinine ratio (UPC) 120 days p.i. that was elevated, compared with the ratio 90 days p.i. in 8 out of 17 animals. However, the difference was not statistically significant, the chosen cut-off of <1 appears to be too high (see below) and the method used to determine the UPC was not stated. In a naturally infected, 6-year-old SCWT in Canada, mentioned above, which was initially presented with lameness, peripheral lymphadenopathy, anorexia and weakness, ACAC of 176 U/ml and an elevated UPC (8.58) were found (Horney and Stojanovic 2013). In addition to supportive treatment for a suspected familial, breed-related PLN, doxycycline was administered (5 mg/kg b.i.d. for 4 weeks). ACAC subsequently decreased to 41 U/ml and the UPC to 1.73. Results of the latter study indicate that ACAC could represent a test able to predict which dogs are predisposed for development of LN or which could facilitate the diagnosis of LN. The correlation between (high) ACAC and proteinuria in dogs (without preselection based on age) has not been previously investigated.
Recently, we evaluated 103 canine samples: single samples of serum and urine provided by European veterinarians with the request for Quant C6 ELISA (serum; performed according Levy et al. 2008 ) und UPC (urine; for methods see Table 4 ) during 2009 (Pantchev 2014 . Submissions were received from Germany and other European countries (n = 71 from Germany, n = 7 from Austria, n = 1 from the Czech Republic, n = 4 from Denmark, n = 1 from France, n = 4 from Finland, n = 2 from Luxembourg, n = 6 from the Netherlands, n = 2 from Norway and n = 5 from Sweden). Data were obtained by testing serum and urine in parallel. Subsequently, samples were divided into 3 groups on the basis of their ACAC: <10, 10 -30 and >30 U/ml and a statistical comparison (CS) with their UPC value (>= 0.6 as a cut-off) was conducted. In total, 55 samples had an UPC greater than or equal to 0.6 (53.4 %; 95 % CI: 43.3 -63.3) and 46 dogs showed an ACAC above 30 U/ml (44.7 %; 95 % CI: 34.9 -54.8). Dogs with ACAC in the moderate-to-high range (over 30 U/ml; group 3) also showed a statistically significantly higher probability of increased UPC (greater than or equal to 0.6 according to IRIS criteria) in urine samples compared to dogs with ACAC in the low (10 -30 U/ ml; group 2) and negative to very low range (under 10 U/ml; group 1; Table 4 ). 
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On the other hand, groups 1 and 2 showed no difference with regard to increased UPC (Table 4) . Dogs from group 3 with ACAC over 30 U/ml (median 137 U/ml) and elevated UPC (median 6.5) were also significantly younger (average age of 5.5 years, median 5 years) compared to dogs from groups 1 and 2 with an elevated UPC (median 1.4), but ACAC was less than or equal to 30 U/ml (average age of 7.9, median 9 years). This corroborates the above mentioned results by Dambach et al. (1997) for LN based on 49 canine cases with renal lesions putatively associated with B. burgdorferi infection. This might indicate that proteinuria in dogs with C6 antibody levels lower than or equal to 30 U/ml occurs coincidentally and might have another genesis as proposed by Dambach et al. (1997) . Within Group 3 (>30 U/ml) 11 of 46 dogs (23.9 %; 95% CI: 12.5 -38.8) with UPC below 0.6 also showed a lower median ACAC (94 versus 137 U/ml); only 4 of these 11 dogs (36.4 %; 95% CI: 9.8 -69.9) showed ACAC >100 U/ml, compared with 21 of 35 dogs (60 %; 95% CI: 42.1 -76.2) with ACAC >100 U/ml and increased UPC; however, this difference was not significant (p = 0.435). Another study in dogs showed a median UPC of 5.7 (0.47 to 43.4) for glomerulonephritis, 22.5 (11.2 to 46.6) for amyloidosis and 2.9 (1.5 to 10.5) for chronic interstitial nephritis (CIN; Center et al. 1985) . So it is suggested that UPC in dogs is usually less than 5 with CIN, whereas primary glomerular disease is associated with UPC above 5. This corresponds well to the median value of 6.5 for UPC found in our study for dogs in group 3 (see above). Our data suggest that ACAC, in particular a concentration over 30 U/ml, in combination with a corresponding history can serve as a marker of LN in dogs. Further studies with a larger number of samples are needed to show whether an ACAC above 100 U/ml can be regarded as high and may indicate an early form of LN in dogs without proteinuria. The correlation between high antibody levels and disease has generally been disputed (e.g. Littman 2013). A study in which cases of high ACAC in asymptomatic dogs were found (Levy et al. 2008) , might further support this hypothesis. However, no haematology, clinical chemistry or urine analyses were performed by Levy et al. (2008) . While dogs were clearly described as asymptomatic, they were not defined as healthy as suggested by Dantas-Torres and Otranto (2014b). For example, it is not known whether these dogs with initial ACAC in the moderate-to-high groups (Levy et al. 2008) may have had proteinuria. Whether ACAC also correlates with the level of specific immune complexes (which were higher in dogs with clinical signs of infection), as proposed by Goldstein and Atwater (2006) , should be a topic for further studies. In addition to the above retrospective study comparing ACAC with UPC in a dog collective (Table 4) , we evaluated data from 15,757 canine serum samples submitted by veterinarians for a Lyme Quant C6 ELISA only (for methods see above) in 2009 to 2013 (previously unpublished data). The largest fraction of animals was the group under 10 U/ml (n = 9,669; 61.4 %; 95 % CI: 60.6 -62.1). The next group with 10 -30 U/ml contained 14.4 % of the cases (n = 2,274; 95 % CI: 13.9 -15) and the third group with ACAC >30 U/ml contained 24.2 % (n = 3,814; 95 % CI: 23.5 -24.9). The differences in group 1 and 3 with ACAC under 10 U/ml and over 30 U/ml were statistically significant compared with the dogs with suspected LN (parallel testing for ACAC in serum and UPC in urine; (Hanincova et al., 2013) . Other relevant effects might include co-infections or co-diseases and a shift in prophylactic methods used against ticks and in the frequency or type of vaccinations (see below). In dogs with suspected LN, the importance of testing the band pattern in immunoblot assays is also highlighted (Littman 2013) . In one suspected case tested in our laboratory (hunting crossbreed dog, 5 years old; previously unpublished data), the immunoblot test showed a field infection with almost all specific bands reacting positively, including VlsE, but without the classic vaccine band OspA (Fig. 10) . The dog also showed severe proteinuria (UPC of 17.8), hypoalbuminaemia, azotaemia, anaemia, and a high ACAC of 430 U/ml. In comparison, the total IgG level, measured using a non-C6/VlsE-based whole-cell ELISA (B. 
Canine granulocytic anaplasmosis (CAG)
It is essential to take into consideration co-infections with Borrelia in the diagnostic workflow of CAG. Studies show that dogs co-infected with A. phagocytophilum and Borrelia spp. run twice the risk of developing disease with clinical signs such as lameness, fever, lethargy, joint pain (swelling) and anorexia compared to with single infections with either pathogen (Beall et al. 2008) . The concurrent presence of an intracellular (Anaplasma spp.) and extracellular (Borrelia spp.) infection may lead to an adverse immunological interaction during the infection course (Krupka et al. 2007 ).
In the majority of dogs, the clinical signs of CAG are non-specific and confined to the acute phase of the infection (Diniz and Breitschwerdt 2012 only 11.7 % were under oder equal the age of 1 year (Greig et al. 1996) . In a Swedish study, 28.6% of the dogs were over the age of 9 and 0% under the age of 1 (Egenvall et al. 1997 ). The pattern is similar in humans, as patients are commonly in the 50-to 60-year age range, with children only rarely affected (Diniz and Breitschwerdt 2012) . A possible explanation might be that repeated reinfection is necessary (hence older dogs), or a fully developed immune system is required, because Anaplasma spp. impact on various immunological processes in order to survive (Egenwall et al. 1997; Carrade et al. 2009; Woldehiwet 2010 ). There appears to be a degree of seasonality, in parallel with the emergence of ticks (approximately from April to September; Kohn et al. 2008; Carrade et al. 2009 ). The characteristic clinicopathological abnormalities and the options for specific diagnosis are illustrated in the form of a diagram in Table 6 on the basis of three case examples (one each from Germany, the Netherlands and Austria). Among the clinicopathological abnormalities, thrombocytopenia is the most important alteration in more than 80 % of cases (Greig et al. 1996; Kohn et al. 2008; Carrade et al. 2009; Diniz and Breitschwerdt 2012) . In one study, over half of the dogs reacted positively in a platelet-bound antibody test (Kohn et al. 2008) . Other important abnormalities are lymphopenia (approx. 50 %), anaemia (approx. 60 %; mild to moderate, non-regenerative and normochromic), occasionally hypoalbuminaemia (mild to moderate) and an increase in alkaline phosphatase and possibly other liver enzymes such as alanine aminotransferase (Table 6 ). Proteinuria has been also described. A relatively new but definitely additional promising test appears to be the measurement of C-reactive protein (CRP), which can increase by up to tenfold in the acute phase of the disease (Pantchev 2010a) . CRP levels might also be useful in monitoring the success of treatment, as they are not influenced by the administration of glucocorticoids, for example (KjelgaardHansen et al. 2006) . Because of the seronegativity of some clinical cases (see Table 6 ), a confirmed diagnosis of CAG, from a single diagnostic test, may not be sufficient. Following experimental infection (with various isolates; i.v. with autologous infected neutrophils, not with ticks), dogs tested positive by PCR (blood) from 2 days p.i., seroconversion occurred after 10 -14 days p.i. using IFA, and morulae were visible in blood smears between days 10 and 11 p.i. (Scorpio et al. 2011) . This shows that the results of diagnostic tests will vary according to the time point post-infection (Fig. 11) and that concurrent use of serology and PCR will therefore increase the likelihood of an accurate diagnosis ( Table 7) . The options for specific diagnosis in veterinary practice are limited to the detection of intracytoplasmatic inclusions (morulae) in neutrophils (in stained blood smears) during the acute infection phase and to indirect serological procedures using the SNAP ® 4Dx ® rapid test (currently available as SNAP ® 4Dx ® Plus for the additional detection of antibodies to Ehrlichia ewingii). This assay detects antibodies (qualitatively; 17 -30 days p.i.; Scorpio 
Serology PCR
Detects the immunological antibody response of the infected host Detects nucleic acid of the infectious agent Antibodies persist over time -suitable for screening The infectious agent (or its DNA) must be present in the sample -suitable in the acute phase of the disease
The immune response takes time, so clinical symptoms may appear before a measurable antibody response A positive result indicates the presence of the agent, but a negative result does not necessarily rule out infection et al. 2011) to a major surface protein (p44/MSP2) of A. phagocytophilum. Antibodies to Anaplasma platys are also detected, as was shown in a experimental study ). An advantage of this test is the option of simultaneously detecting antibodies to the C6 peptide of Bbsl, and for dogs with a history of travel in endemic regions, antibodies to E. canis and heartworm antigen. Further diagnostic options in reference laboratories include IFA for serology and specific real-time PCR tests for molecular detection. IFA allows semi-quantitative determination of antibody levels in blood (titre determination). This is useful in order to observe fluctuations (increase or decrease) in antibody response. Seroconversion occurs two to five days after the initial appearance of morulae in peripheral blood (see above; Scorpio et al. 2011) . Titres then increase within 2 to 3 weeks (see also Table 6 ; Scorpio et al. 2011) and decrease between 4 to 8 months after the detection of inclusions within a blood smear and treatment with doxycycline (Egenwall et al. 1997 ). An increase in titres in some dogs in the Swedish study after the next (tick) season can most probably be explained by asymptomatic re-infections. A disadvantage of the A. phagocytophilum IFA compared with tests using specific peptides (e.g. SNAP ® 4Dx ® ; Chandrashekar et al. 2010 ) is possible cross-reactivity with E. canis antibodies. The strength of the cross-reactivity of such sera when tested with A. phagocytophilum antigen increases with the duration of the E. canis infection and the E. canis antibody titre (Harrus et al. 2012) . For example, in dogs infected experimentally with E. canis, no cross-reactivity with A. phagocytophilum antigens was observed in the acute phase; however, cross-reactive antibodies were first detected on day 55 p.i. and were then found in all dogs by day 150 p.i. (Harrus and Waner 2011) . The PCR for direct detection of pathogen DNA in blood is more sensitive than the microscopic scanning of stained blood smears, demonstrated with experimentally infected dogs. The dogs tested positive for Anaplasma spp. DNA, 6 to 8 days before morulae could be detected in peripheral blood (Scorpio et al. 2011 ).
The authors also showed that in the canine model the bacterial load (quantitative real-time PCR) correlated with platelet decline, observed until the end of the study period (60 days p.i.). However, there pathogen DNA is present in blood samples and can be detected by PCR; no immune response occurred so far, antibody detection is not possible; dog B: shows clinical signs: PCR result is positive although the number of pathogens in the blood is already decreasing; serology is also positive due to a suffi cient immune response, but the antibody level is still low (rising; color triangle represents overlap zone of both tests), dog C: weeks or months elapsed since infection; the dog may be asymptomatic: PCR is negative as pathogens are no longer circulating in the blood; serology is positive with a potentially high IFA titre; schematic display (modifi ed according to Pantchev 2010b).
Positive Result
Blood PCR Serology Dog A Dog B Dog C were some differences based on the A. phagocytophilum strain and cell type used for i.v. infection. PCR allows the differentiation of A. phagocytophilum and A. platys (the latter is important in dogs with a history of travel to endemic regions; Dyachenko et al. 2012) , which again can crossreact serologically ). There have been recent reports of PCR-positive findings in skin biopsies from dogs with skin lesions of unknown origin and a histological picture of vasculitis (Berzina et al. 2014) . The involvement of A. phagocytophilum in such cases and the interpretation of DNA detection in skin tissue require further clarification.
Canine babesiosis
For the diagnosis of canine babesiosis the following points should be considered (according to Pantchev 2012a): anamnesis including history of travel in endemic areas and tick infestation, blood transfusion or other possible non-vector-borne transmission routes (see above), clinical findings and laboratory abnormalities, direct pathogen detection in blood smears stained using Giemsa, Wright or Diff-Quik or DNA detection by PCR, and indirect pathogen detection by serology (ELISA, IFA). Typical laboratory findings, which differ depending on the Babesia species (see Tables 2 and 3) , are haemolytic anaemia (initially non-regenerative, normocytic and normochromic, later regenerative, macrocytic and hypochromic), secondary immunohaemolytic anaemia with positive Coombs test, spherocytes, leukocytosis with a left shift in many cases, and thrombocytopenia and neutropenia. Further clinicopathological abnormalities are haemoglobinuria, bilirubinuria, bilirubinaemia and proteinuria (due to intravascular haemolysis), an increase in aspartate aminotransferase, alanine aminotransferase (hepatopathy) and azotaemia, and chronic hypoalbuminaemia (hepatopathy and glomerulopathy) (Ayoob et al. 2010; Birkenheuer 2012) . The specific diagnostic options in veterinary practice during the acute phase are limited to stained blood smears, which allow differentiation between large (Fig. 12A ) and small Babesia species. Capillary blood or buffy coat preparations are more suitable in many cases, because infected erythrocytes sequestrate in capillaries and Babesia tend to invade reticulocytes rather than mature erythrocytes (Irwin 2009; Ayoob et al. 2010; Ogo et al. 2011) . Differentiation of large versus small forms is usually possible, except in rare cases of atypical 
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B. canis stages which unexpectedly can take on a small, rounded form (Fig. 12B) . In these cases, PCR is indicated to ensure reliable differentiation (see also Demeter et al. 2011 Eiras et al. 2014 ) reacted clearly positively as well (so far unpublished data). R. vitalii represents a large piroplasm occurring in Brazil and Argentina, and is proposed as the causative agent of canine rangeliosis (known as "bloody ears" disease; Eiras et al. 2014 ; see also Table 2 ). In general, serology cannot distinguish between animals with an acute or chronic infection (Irwin 2009; Ogo et al. 2011 Brandao et al. 2003) . The disappearance of Babesia from the blood approximately correlated with the maximum antibody titres. Interestingly, antibody titres >1:320 showed a protective effect. In the latter experimental study parasitaemia had been observed 2 days p.i., which is earlier compared to the typical case in natural (tick-borne) infections of 6 to 20 days p.i. (Brandao et al. 2003) . This time lag may be due to the fact that, in the study cited, the dogs were inoculated with erythrocytes containing merozoites, while in natural settings the sporozoites are the initial stages introduced by the ticks. After sporozoite-induced infection (subcutaneously with a French B. canis isolate) the prepatent period (blood smear from ear veins) was 5 -7 days, and it was slightly shorter than the incubation period for fever (6 -8 days; Uilenberg et al. 1981) .
The advantages of serology are the diagnosis of cases with low-level or intermittent parasitaemia (Uilenberg et al. 1981; Brandao et al. 2003) and of chronic infections (Irwin 2009 ). The limitations are cross-reactions (especially between different Babesia species, see above) and false-negative findings in young or immunosuppressed dogs, or early in S42 the course of infection before seroconversion has occurred (Ayoob et al. 2010 ). This final limitation requires the testing of paired sera, with the second taken after an interval of 2 to 3 weeks. It should also be considered that dogs in B. canis-endemic regions may show high titres without showing clinical signs (Ayoob et al. 2010) . Specific treatment with imidocarb and diminazene early in the course of infection (approx. 1 week p.i. after direct detection of B. canis in blood) prevented seroconversion in one out of eight dogs, as shown with an experimental model (Beugnet et al. 2014) . Another important aspect of Babesia diagnostics in dogs is the use of PCR tests. The detection limit of PCR protocols is given variously as 50 organisms per ml in one protocol and 9 per µl in another (reviewed by Irwin 2009 ). In one study, it was 1,300 times lower (better) than the detection limit of light microscopy (Birkenheuer et al. 2003) . A single microscopic blood smear test, compared with PCR as the established gold standard, had a relative sensitivity of 38 % and a relative specificity of over 99 %; there was moderate agreement between the results of the two methods (kappa = 0.54; Globokar Vrhovec 2013) . In the patient cohort tested by Globokar Vrhovec (2013; dogs living in Germany), microscopy detected Babesia significantly more frequently in animals that had stayed within Germany compared to animals with a history of travel or imported animals. These data agree with the serological data obtained for Germany (see above). It is possible that a larger proportion of the animals with a history of travel were tested preventively irrespective of symptoms, whereas the animals that had stayed within Germany were tested on the basis of clinical suspicion. Another major advantage of PCR is that, following a positive Babesia PCR result, differentiation of Babesia species can subsequently be performed by either species-specific real-time PCR (Dyachenko et al. 2012) , or SSU rDNA amplification with subsequent sequencing (Beck et al. 2009 ). This is important in order to select an appropriate treatment, as large and small Babesia require different therapeutic approaches. The treatment of choice is imidocarb for large forms and a combination of atovaquone and azithromycin for B. gibsoni (Pantchev 2012a; Birkenheuer 2012) . PCR itself has limitations, especially when no organisms are present in the blood (as in chronically infected animals), or if the parasitaemia is intermittent (Brandao et al. 2003; Irwin 2009 ). In these cases it is helpful to repeat PCR tests, or combine PCR with serology. In the above-mentioned study, which evaluated data from three different diagnostic procedures for B. canis (dogs living in Germany, 2004 (dogs living in Germany, to 2006 , antibodies were detected (by IFA) in 11.5 % (n = 2,653) of dogs, parasitic stages were found in Giemsa-stained blood smears in 2.1 % of samples (n = 9,966) and DNA was detected (by conventional PCR) in 3. 
Prophylaxis
Prophylaxis is based on a range of different actions aimed at preventing infection or the development of disease following infection. There are four basic cornerstones of prophylaxis for TBD: vector prophylaxis with acaricides / repellents (directed against the ticks which carry the pathogens), chemoprophylaxis (generally targeted directly against the pathogen), vaccination (by pathogen-specific vaccination) and behavioural prophylaxis (reducing vector exposure by avoiding risk areas during the vector's periods of activity, for example; Pantchev 2013).
S43

Acaricides / repellents
According to the product information for certain acaricide-based products, some ticks already present at the time of treatment are not killed within the first 48 hours and remain attached and visible. It is advisable to remove such ticks mechanically before starting prophylaxis. In one study, rotating devices (in order of success: tick-pliers (tick remover / extractor), lasso, tick twister) proved better than pulling devices (tweezers, tick card). However, in regard to the tick mouthparts, there was no difference between the two groups (Robisch 2010).
With the above-mentioned in mind, it is important to begin prophylaxis before the first ectoparasite exposure, e.g. efficacy against ticks develops within two days after applying a collar (using the example of imidacloprid/flumethrin in Seresto ® ). Ticks infesting dogs in Europe do not tend to harm their hosts directly, with the main risk being that pathogen transmission can occur and disease potentially results from the infection. The applied compounds show different effects on ticks (repellency, antifeeding effect, disruption of attachment, expellency, killing effect), so it is important to use suitable acaricides to kill the ticks as quickly as possible before pathogens are released. It is even better to prevent ticks from attaching (tick repellency sensu stricto; Halos et al. 2012) . As one study showed, compounds with a repellent effect can prevent TBD (Anaplasma / Borrelia) more efficiently than active substances, which only show a killing effect (Blagburn et al. 2005) . It is therefore important for veterinarians to take note of the relevant product information. Hovius et al. 2000) . Although the effects of co-infections in the dog have not yet been studied in an experimental model, co-infection with Bbss and B. garinii in a murine model showed a more severe progression of symptoms than an infection with Bbss alone (Hovius et al. 2007 ). Because it is assumed that OspA antibodies (the basis of the vaccine) are not cross-protective among Borrelia species (Straubinger et al. 2002; Töpfer 2005) , it would be worth considering whether the vaccination regime should include other species (B. garinii / B. afzelii) in addition to the canine pathogen Bbss recognized to date. Based on its principle of action (mainly induction of antibodies to OspA; see above), vaccination prevents future infection, because anti-OspA antibodies ingested during feeding inactivate the Borrelia directly within the tick's gut . Before vaccinating dogs, therefore, it is important to test adult dogs with an unknown infectious status and dogs that are already potentially infected. One reason is, that vaccination has no effect on an existing Borrelia infection. Another reason is that dogs with high ACAC following vaccination with a lyophilized product show very high levels of circulating immune complexes (Greene et al. 2012 ). Hebert and Eschner (2010) , for example, included dogs in their vaccination programe only if they showed ACAC below 30 U/ml, together with normal blood and urine values. On the other hand, dogs with ACAC over 30 U/ml were treated (doxycycline 10 mg/kg q.d. for 28 days) and followed up after 30 days (laboratory tests and clinical examination). Dogs with no abnormal findings were admitted to the vaccination programe, with the Lyme Quant C6 ELISA being repeated six months later (see above). Dogs with glomerulonephritis and suspected LN may require a longer period of doxycycline administration. In such cases (UPC above 0.5), specific recommendations regarding treatment and monitoring can be found in Goldstein et al. (2013) . (Schetters et al. 1995; Schetters 2005; Irwin 2009; Ayoob et al. 2010) . However, this vaccine is not currently available on the European market.
Babesia vaccination
Babesia chemoprophylaxis
The compound imidocarb, which has been used for chemoprophylaxis of infection with large Babesia, may induce potentially serious adverse effects, mainly due to cholinesterase inhibition, including also anaphylactoid reactions and renal or liver impairment (Ayoob et al. 2010; Dyachenko et al. 2012) . Moreover, its prophylactic effect is of variable duration (reported to range from 2 to 6 weeks at a dose of 3 -6 mg/kg BW; Deplazes et al. 2006) or even not present in sporozoite-induced experimental infections with a French B. canis isolate (6 mg/ kg BW 2 to 5 weeks before infection; Uilenberg et al. 1981) . In combination, it is either not recommended for use as chemoprophylaxis (Ayoob et al. 2010) or only for dogs under one year of age (with the recommendation that older animals should be treated if symptomatic; Tenter and Deplazes 2006) . Finally, imidocarb does indeed eliminate B. canis, but it also prevents the development of immunity, leaving dogs susceptible to reinfection (Brandao et al. 2003) .
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